
RL 1.25mg Tablet
Marketer
Sunij Pharma Pvt Ltd
Salt Composition
Ramipril (1.25mg)
Overview RL 1.25mg Tablet
A 1.25mg RL tablet is a common treatment for hypertension and congestive heart failure, often prescribed post-myocardial infarction. It significantly reduces the risk of future cardiac events, including stroke. This medication can be administered independently or concurrently with other drugs, with or without food. Consistent daily dosing maximizes efficacy; continued use is crucial, even with symptom remission or controlled blood pressure, as untreated hypertension can worsen. While many experience no symptoms, discontinuation is ill-advised. This medication boasts a strong safety profile for prolonged use. Complementary lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderated alcohol consumption, and a doctor-recommended low-sodium diet, enhance treatment effectiveness. Dry cough, headache, and tiredness are frequently reported, typically resolving spontaneously. Persistent or bothersome side effects warrant medical attention. Prior to commencing treatment, disclose any renal or hepatic impairment to your physician. Pregnant or lactating individuals should seek medical guidance before use. Regular monitoring of renal function, blood pressure, and serum potassium levels may be undertaken by your doctor during treatment.
Primary Ingredients of RL 1.25mg Tablet
No text provided to rephrase.
Uses of RL 1.25mg Tablet
Managing elevated blood pressure | Reducing the risk of cardiovascular events such as myocardial infarction and cerebrovascular accident | Cardiac insufficiency management
Major Benefits of RL 1.25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 1.25mg RL tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of RL 1.25mg Tablet:
- Dry cough
- Headache
- Fatigue
How to use RL 1.25mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 1.25mg RL tablet can be administered with or without food, though consistent timing is recommended.
How RL 1.25mg Tablet works:
Each 1.25mg RL tablet contains an ACE inhibitor that lowers cardiac workload and dilates blood vessels, thereby improving blood flow and cardiac pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of RL 1.25mg tablets and alcohol can result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Administering a 1.25mg RL tablet during pregnancy poses a confirmed risk to the fetus. Exceptions may exist in life-threatening emergencies where a physician deems the potential benefit outweighs the risk. Physician consultation is crucial.
Breast feedingCONSULT YOUR DOCTOR
Administration of 1.25 mg RL tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 1.25mg RL tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using RL 1.25mg tablets, as dose modification may be necessary. Physician consultation is advised. Routine blood pressure checks are recommended to guide dosage changes.
LiverCAUTION
Patients with liver impairment should use RL 1.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Report any jaundice symptoms to your doctor during treatment.
What if you forget to take RL 1.25mg Tablet :
Omit any missed RL 1.25mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About RL 1.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Carboxylic acid dipeptide derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavior Class | ACE inhibitors |
